12 Health Care Stocks Moving In Wednesday's After-Market Session

Aditxt, Inc.
Agape ATP Corp.
Dogwood Therapeutics Inc
Eloxx Pharmaceuticals, Inc.
Elicio Therapeutics, Inc

Aditxt, Inc.

ADTX

0.00

Agape ATP Corp.

ATPC

0.00

Dogwood Therapeutics Inc

DWTX

0.00

Eloxx Pharmaceuticals, Inc.

ELOX

0.00

Elicio Therapeutics, Inc

ELTX

0.00

Gainers

  • Aditxt (NASDAQ:ADTX) stock moved upwards by 20.4% to $0.01 during Wednesday's after-market session.
  • Agape ATP (NASDAQ:ATPC) shares moved upwards by 17.21% to $3.2. The company's market cap stands at $2.8 million.
  • NeuroSense Therapeutics (NASDAQ:NRSN) stock moved upwards by 10.65% to $0.78. The market value of their outstanding shares is at $25.2 million.
  • Spero Therapeutics (NASDAQ:SPRO) stock increased by 8.53% to $2.29. The market value of their outstanding shares is at $160.3 million.
  • Dogwood Therapeutics (NASDAQ:DWTX) shares moved upwards by 6.04% to $1.58. The market value of their outstanding shares is at $50.4 million.
  • iSpecimen (NASDAQ:ISPC) stock increased by 5.49% to $2.69. The company's market cap stands at $3.7 million.

Losers

  • Eloxx Pharma (NASDAQ:ELOX) shares declined by 15.0% to $12.0 during Wednesday's after-market session. The market value of their outstanding shares is at $43.8 million.
  • Elicio Therapeutics (NASDAQ:ELTX) shares decreased by 14.44% to $4.03. The company's market cap stands at $52.6 million.
  • Rafael Holdings (NYSE:RFL) shares fell 14.07% to $2.26. The company's market cap stands at $132.0 million. The company's, Q3 earnings came out 4 days ago.
  • LeonaBio (NASDAQ:LONA) stock fell 11.31% to $7.3. The company's market cap stands at $74.0 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares decreased by 8.93% to $3.98. The company's market cap stands at $2.3 million.
  • Picard Medical (AMEX:PMI) stock declined by 8.38% to $0.17. The company's market cap stands at $15.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.